How to buy Imago BioSciences stock (Imago BioSciences)

Imago BioSciences is a biotechnology & medical research business based in the US. Imago BioSciences shares (IMGO) are listed on the NASDAQ and all prices are listed in US Dollars. Imago BioSciences employs 41 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Imago Biosciences stock

Buy Imago BioSciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Imago BioSciences stock price (NASDAQ: IMGO)

Use our graph to track the performance of IMGO stocks over time.

Imago BioSciences shares at a glance

• Key figures

Information last updated 2024-01-24.

52-week range	$0.00 - $0.00
50-day moving average more info button	$31.73
200-day moving average more info button	$19.83
Wall St. target price	$36.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-2.16

Is it a good time to buy Imago BioSciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Imago BioSciences financials

Gross profit TTM	$0
Return on assets TTM	-18.55%
Return on equity TTM	-30.74%
Profit margin	0%
Book value	$5.11
Market Capitalization more info button	$1.2 billion

TTM: trailing 12 months

Imago BioSciences share dividends

We're not expecting Imago BioSciences to pay a dividend over the next 12 months.

You may also wish to consider:

Imago BioSciences overview

Imago BioSciences, Inc. , a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California. As of January 11, 2023, Imago BioSciences, Inc. operates as a subsidiary of Merck Sharp & Dohme Corp. .

Frequently asked questions

null
What percentage of Imago BioSciences is owned by insiders or institutions?
Currently 3.725% of Imago BioSciences shares are held by insiders and 100.128% by institutions. How many people work for Imago BioSciences?
Latest data suggests 41 work at Imago BioSciences. When does the fiscal year end for Imago BioSciences?
Imago BioSciences's fiscal year ends in December. Where is Imago BioSciences based?
Imago BioSciences's address is: 329 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 What is Imago BioSciences's ISIN number?
Imago BioSciences's international securities identification number is: US45250K1079